IGF-1R, c-Met, Src) have already been proven to co-operate with HER family to operate a vehicle tumour growth also to confer resistance to therapy including treatment with HER inhibitors23C26, 31, 32

IGF-1R, c-Met, Src) have already been proven to co-operate with HER family to operate a vehicle tumour growth also to confer resistance to therapy including treatment with HER inhibitors23C26, 31, 32. cells. From the three HER2 overexpressing cell lines within